Outcomes and inflammation changes in different types of immunocompromised patients with critically ill COVID-19 admitted to ICU: a national multicenter study
Abstract Background Immunocompromised patients face higher risks of Severe Acute Respiratory Syndrome Coronavirus 2 infection and co-infections, leading to a possibility of high disease severity and poor outcomes. Conversely, immunosuppression can mitigate the excessive inflammatory response induced...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMC
2024-10-01
|
| Reeks: | BMC Pulmonary Medicine |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1186/s12890-024-03362-6 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
